NCT05505292View on ClinicalTrials.gov

Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions
Dry Eye
Interventions
DRUG

Lifitegrast 5% Ophthalmic Solution

Dosed twice a day for 8 weeks

OTHER

Lifitegrast Ophthalmic Solution Vehicle

Dosed twice a day for 8 weeks

Trial Locations (1)

10036

State University of New York College of Optometry Clinical Vision Research Center, New York

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

Bausch & Lomb Incorporated

INDUSTRY

lead

State University of New York College of Optometry

OTHER